Leica Biosystems PD-L1 BOND antibody

Wednesday, 05 December, 2018 | Supplied by: Leica Microsystems Pty Ltd



Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.

The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.

Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.

Online: www.leica-microsystems.com
Phone: 1800 625 286
Related Products

Larodan research-grade natural and synthetic phospholipids

Larodan develops a comprehensive range of research-grade lipids for use as analytical standards...

Enzo SCREEN-WELL Stem Cell Library

Enzo's SCREEN-WELL Stem Cell Library is a collection of 130 compounds that can be used for...

Thermo Fisher Scientific SmartPlate

Thermo Fisher Scientific's SmartPlate is a robust, easy-to-handle, sustainable plate design...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd